C07K 16/4216
Against anti-viral ig
Official title: {against anti-viral Ig}
C07K16/4216 (Against anti-viral ig) appears on 52 US grants and 40 published applications in this corpus.
Search patents in C07K- Granted patents
- 52
- Published applications
- 40
- Assignees
- 39
- Inventors
- 110
- Latest grant
- 3 May 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 1 |
| 2002 | 2 | 2 |
| 2003 | 1 | 3 |
| 2004 | 2 | 4 |
| 2005 | 2 | 2 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 2 | 2 |
| 2009 | 1 | 0 |
| 2010 | 1 | 3 |
| 2011 | 1 | 1 |
| 2012 | 0 | 2 |
| 2013 | 3 | 3 |
| 2014 | 0 | 1 |
| 2015 | 2 | 1 |
| 2016 | 3 | 4 |
| 2017 | 3 | 3 |
| 2018 | 1 | 1 |
| 2019 | 2 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
| 2025 | 0 | 2 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Methods for producing and using IgY antibodies targeting the middle east respiratory syndrome coronavirus spike protein to treat or prevent MERS-CoV infection3 May 2022US 11,319,382 B1King Abdulaziz University
- Consensus/ancestral immunogens16 Mar 2021US 10,946,090 B2Duke University
- Anti-hepatitis C antibodies and antigen binding fragments thereof24 Sep 2019US 10,421,805 B2United Kingdom Research and Innovation
- Humanized monoclonal antibodies and methods of use15 Jan 2019US 10,179,822 B2Dana-Farber Cancer Institute, Inc.
- HIV-1 V3 mimotopes capable of inducing cross-clade neutralizing antibodies13 Nov 2018US 10,125,173 B2Texas Biomedical Research Institute
- Glycoform specific nanobodies and methods of use12 Jun 2025US 2025/0188193 A1The Rockefeller University
- Mini bodies as vaccines for hiv23 Jan 2025US 2025/0026857 A1Pomona Ricerca S.r.l.
- Glycoform specific nanobodies and methods of use9 May 2024US 2024/0150494 A1The Rockefeller University
- Hiv vaccine immunogens1 Feb 2024US 2024/0033341 A1
- Influenza vaccines and methods of use thereof10 Mar 2022US 2022/0073648 A1
Most cited
By later US patents
- Variable heavy and light chain regions of murine monoclonal antibody 1F767US 6,057,421 AImmpheron, Inc. · 2000
- Method for reducing T cell-mediated cytotoxicity in HIV using anti-idiotypic antibody36US 6,146,627 ASidney Kimmel Cancer Center · 2000
- Induction of antibody response to solid tumors with anti-idiotype antibodies30US 5,053,224 A1991
- Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates28US 5,866,694 A1999
- Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins25US 8,071,107 B2Duke University · 2011